{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:09:56Z","timestamp":1761512996054},"reference-count":125,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Transl Oncol"],"published-print":{"date-parts":[[2011,6]]},"DOI":"10.1007\/s12094-011-0670-5","type":"journal-article","created":{"date-parts":[[2011,6,29]],"date-time":"2011-06-29T15:55:48Z","timestamp":1309362948000},"page":"368-377","source":"Crossref","is-referenced-by-count":13,"title":["PET-CT in the staging and treatment of non-small-cell lung cancer"],"prefix":"10.1007","volume":"13","author":[{"given":"Patricia","family":"Ibeas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Blanca","family":"Cantos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 Manuel","family":"Gasent","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bego\u00f1a","family":"Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariano","family":"Provencio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,6,29]]},"reference":[{"key":"670_CR1","volume-title":"TNM classification of malignant tumours","year":"2002","unstructured":"Sobin LH, Wiyyekind C (eds) (2002) TNM classification of malignant tumours, 6th edn. John Wiley & Sons, New York","edition":"6th edn."},{"key":"670_CR2","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/S1470-2045(04)01564-5","volume":"5","author":"J. Vansteenkiste","year":"2004","unstructured":"Vansteenkiste J, Fischer BM, Dooms C, Mortensen J (2004) Positron-emission tomography in prognostic and therapeutic assessment of lung cancer: systematic review. Lancet Oncol 5:531\u2013540","journal-title":"Lancet Oncol"},{"key":"670_CR3","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1001\/jama.285.7.914","volume":"285","author":"M.K. Gould","year":"2001","unstructured":"Gould MK, Mclean CC, Kuschner WG et al (2001) Accuracy of positron emission tomography for diagnosis of pulmonary nodules and mass lesions: a meta-analysis. JAMA 285:914\u2013924","journal-title":"JAMA"},{"key":"670_CR4","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1016\/j.athoracsur.2004.07.072","volume":"79","author":"H. Nomori","year":"2005","unstructured":"Nomori H, Watanabe K, Ohtsuka T et al (2005) Visual and semiquantitative analyses for F-18 fluorodeoxyglucose PET scanning in pulmonary nodules 1 cm to 3 cm in size. Ann Thorac Surg 79:984\u2013988","journal-title":"Ann Thorac Surg"},{"key":"670_CR5","doi-asserted-by":"crossref","first-page":"2682","DOI":"10.1002\/1097-0142(19871201)60:11<2682::AID-CNCR2820601118>3.0.CO;2-H","volume":"60","author":"K.B. Nolop","year":"1987","unstructured":"Nolop KB, Rodees CG, Brudin LH et al (1987) Glucose utilization in vivo by human pulmonary neoplasms. Cancer 60:2682\u20132689","journal-title":"Cancer"},{"key":"670_CR6","first-page":"235","volume":"52","author":"A. Behzadi","year":"2009","unstructured":"Behzadi A, Ung Y, Lowe V, Deschamps C (2009) The role of positron emission tomography in the management of non-small cell lung cancer. Can J Surg 52:235\u2013242","journal-title":"Can J Surg"},{"key":"670_CR7","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1056\/NEJM200007273430404","volume":"343","author":"R.M. Pieterman","year":"2000","unstructured":"Pieterman RM, van Putten JW, Meuzelaar JJ et al (2000) Preoperative staging of non-small-cell lung cancer with positron-emission tomography. N Engl J Med 343:254\u2013261","journal-title":"N Engl J Med"},{"key":"670_CR8","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1016\/j.jtcvs.2005.07.014","volume":"130","author":"J.L. Port","year":"2005","unstructured":"Port JL, Andrade RS, Levin MA et al (2005) Positron emission tomographic scanning in the diagnosis and staging of non-small cell lung cancer 2 cm in size or less. J Thorac Cardiovasc Surg 130:1611\u20131615","journal-title":"J Thorac Cardiovasc Surg"},{"key":"670_CR9","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1378\/chest.122.6.1918","volume":"122","author":"N.C. Gupta","year":"2002","unstructured":"Gupta NC, Rogers JS, Graeber GM et al (2002) Clinical role of F-18 fluorodeoxyglucose positron emission tomography imaging in patients with lung cancer and suspected malignant pleural effusion. Chest 122:1918\u20131924","journal-title":"Chest"},{"key":"670_CR10","doi-asserted-by":"crossref","first-page":"245","DOI":"10.2214\/ajr.175.1.1750245","volume":"175","author":"J.J. Erasmus","year":"2000","unstructured":"Erasmus JJ, McAdams HP, Rossi SE et al (2000) FDG PET of pleural effusions in patients with non-small cell lung cancer. AJR Am J Roentgenol 175:245\u2013249","journal-title":"AJR Am J Roentgenol"},{"key":"670_CR11","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S0003-4975(02)04350-3","volume":"75","author":"H. Kramer","year":"2003","unstructured":"Kramer H, Groen HJM (2003) Current concepts in the mediastinal lymph node staging in suspected lung cancer: comparison of positron emission tomography with F-18 fluorodeoxyglucose and mediastinoscopy. Ann Thorac Surg 75:231\u2013235","journal-title":"Ann Thorac Surg"},{"key":"670_CR12","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1164\/ajrccm\/141.5_Pt_1.1096","volume":"141","author":"R.E. Dales","year":"1990","unstructured":"Dales RE, Stark RM, Raman S (1990) Computed tomography to stage lung cancer. Approaching a controversy using meta-analysis. Am Rev Respir Dis 141:1096\u20131101","journal-title":"Am Rev Respir Dis"},{"key":"670_CR13","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1148\/radiology.213.2.r99nv46530","volume":"213","author":"B.A. Dwamena","year":"1999","unstructured":"Dwamena BA, Sonnad SS, Angobaldo JO, Wahl RL (1999) Metastases from non-small cell lung cancer: mediastinal staging in the 1990s-metaanalytic comparison of PET and CT. Radiology 213:530\u2013536","journal-title":"Radiology"},{"issue":"[Suppl1]","key":"670_CR14","first-page":"147S","volume":"123","author":"E.M. Toloza","year":"2003","unstructured":"Toloza EM, Harpole L, McCrory DC (2003) Noninvasive staging of non-small cell lung cancer: a review of the current evidence. Chest 123[Suppl 1]:147S\u2013156S","journal-title":"Chest"},{"issue":"[Suppl1]","key":"670_CR15","doi-asserted-by":"crossref","first-page":"147S","DOI":"10.1378\/chest.123.1_suppl.147S","volume":"123","author":"G.A. Silvestri","year":"2003","unstructured":"Silvestri GA, Tanoue LT, Margolis ML et al; American College of Chest Physicians (2003) The noninvasive staging of non-small cell lung cancer: the guidelines. Chest 123[Suppl 1]:147S\u2013156S","journal-title":"Chest"},{"key":"670_CR16","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1016\/j.jtcvs.2003.07.030","volume":"126","author":"C.E. Reed","year":"2003","unstructured":"Reed CE, Harpole DH, Posther KE et al; American College of Surgeons Oncology Group Z0050 trial (2003) Results of the American College of Surgeons Oncology Group Z0050 trial: the utility of positron emission tomography in staging potentially operable non-small cell lung cancer. J Thorac Cardiovasc Surg 126:1943\u20131951","journal-title":"J Thorac Cardiovasc Surg"},{"key":"670_CR17","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S0003-4975(02)04350-3","volume":"75","author":"T.P. Graeter","year":"2003","unstructured":"Graeter TP, Hellwig D, Hoffmann K et al (2003) Mediastinal lymph node staging in suspected lung cancer: comparison of positron emission tomography with F-18-fluorodeoxyglucose and mediastinoscopy. Ann Thorac Surg 75:231\u2013235; discussion 235\u2013236","journal-title":"Ann Thorac Surg"},{"key":"670_CR18","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.athoracsur.2004.06.041","volume":"79","author":"Birim","year":"2005","unstructured":"Birim \u00d6, Kappetein AP, Stijnen T, Bogers JJC (2005) Meta-analysis of positron emission tomographic and computed tomographic imaging in detecting mediastinal lymph node metastases in non-small cell lung cancer. Ann Thorac Surg 79:375\u2013381","journal-title":"Ann Thorac Surg"},{"key":"670_CR19","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/j.ejcts.2009.05.044","volume":"36","author":"C. Perigaud","year":"2009","unstructured":"Perigaud C, Bridji B, Roussel JC et al (2009) Prospective preoperative mediastinal lymph node staging by integrated positron emission tomography-computerised tomography in patients with non-small-cell lung cancer. Eur J Cardiothorac Surg 36:731\u2013736","journal-title":"Eur J Cardiothorac Surg"},{"key":"670_CR20","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1177\/030089160609200412","volume":"92","author":"F. Alongi","year":"2006","unstructured":"Alongi F, Ragusa P, Montemaggi P, Bona CM (2006) Combining independent studies of diagnostic fluorodeoxyglucose positron-emission tomography and computed tomography in mediastinal lymph node staging for non-small cell lung cancer. Tumori 92:327\u2013333","journal-title":"Tumori"},{"key":"670_CR21","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1097\/RLU.0b013e3180a1ac87","volume":"32","author":"C. Turkmen","year":"2007","unstructured":"Turkmen C, Sonmezoglu K, Toker A et al (2007) The additional value of FDG PET imaging for distinguishing N0 or N1 from N2 stage in preoperative staging of non-small cell lung cancer in region where the prevalence of inflammatory lung disease is high. Clin Nucl Med 32:607\u2013612","journal-title":"Clin Nucl Med"},{"key":"670_CR22","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.ejcts.2007.09.026","volume":"33","author":"N. Sarraf Al","year":"2008","unstructured":"Al Sarraf N, Aziz R, Gately K et al (2008) Pattern and predictors of occult mediastinal lymph node involvement in non-small cell lung cancer patients with negative mediastinal uptake on positron emission tomography. Eur J Cardiothorac Surg 33:104\u2013109","journal-title":"Eur J Cardiothorac Surg"},{"key":"670_CR23","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.athoracsur.2007.03.081","volume":"84","author":"P.C. Lee","year":"2007","unstructured":"Lee PC (2007) Risk factors for occult mediastinal metastases in clinical stage I non-small cell lung cancer. Ann Thorac Surg 84:177","journal-title":"Ann Thorac Surg"},{"key":"670_CR24","doi-asserted-by":"crossref","first-page":"2300","DOI":"10.1378\/chest.125.6.2300","volume":"125","author":"F.C. Detterbeck","year":"2004","unstructured":"Detterbeck FC, Falen S, Rivera MP et al (2004) Seeking a home for a PET, Part 2: Defining the appropiate place for positron emission tomography imaging in the staging of patients with suspected lung cancer. Chest 125:2300\u20132308","journal-title":"Chest"},{"key":"670_CR25","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1164\/rccm.200202-070SO","volume":"166","author":"S.G. Spiro","year":"2002","unstructured":"Spiro SG, Porter JC (2002) Lung cancer: where are we today? Current advances in staging and nonsurgical treatment. Am J Resir Crit Care Med 166:1166\u20131196","journal-title":"Am J Resir Crit Care Med"},{"key":"670_CR26","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1200\/JCO.2004.09.053","volume":"22","author":"D.G. Pfister","year":"2002","unstructured":"Pfister DG, Johson DH, Azzoli CG et al; American Society of Clinical Oncology (2002) American Society of Clinical Oncology treatment of unresectable non-small-cell lung cancer guideline: update 2003. J Clin Oncol 22:330\u2013353","journal-title":"J Clin Oncol"},{"key":"670_CR27","doi-asserted-by":"crossref","first-page":"879","DOI":"10.7326\/0003-4819-139-11-200311180-00013","volume":"139","author":"M.K. Gould","year":"2003","unstructured":"Gould MK, Kuscher WG, Rydzak CE et al (2003) Test performance of positron emission tomogra phy and computed tomography for mediastinal staging in patients with non-small lung cancer: a meta-analysis. Ann Intern Med 139:879\u2013892","journal-title":"Ann Intern Med"},{"key":"670_CR28","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/S0003-4975(03)00888-9","volume":"76","author":"R.J. Cerfolio","year":"2003","unstructured":"Cerfolio RJ, Ojha B, Bryant AS et al (2003) The role of FDG-PET scan in staging patients with non-small cell carcinoma. Am Thorac Surg 76: 861\u2013866","journal-title":"Am Thorac Surg"},{"key":"670_CR29","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1016\/S0140-6736(02)08352-6","volume":"359","author":"H. Tinteren Van","year":"2002","unstructured":"Van Tinteren H, Hoekstra OS, Smit EF et al (2002) Effectiveness of positron emission tomography in the preoperative assessment of patients with suspected non-small-cell lung cancer: the PLUS multicentre randomised trial. Lancet 359:1388\u20131393","journal-title":"Lancet"},{"key":"670_CR30","doi-asserted-by":"crossref","unstructured":"Passlick B (2004) Mediastinal staging (take home messages). Lung Cancer [Suppl 2]:s85\u2013s87","DOI":"10.1016\/j.lungcan.2004.07.987"},{"key":"670_CR31","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.1200\/JCO.2004.04.126","volume":"22","author":"R.C. Viney","year":"2004","unstructured":"Viney RC, Boyer MJ, King MT et al (2004) Randomized controlled trial of the role of positron emission tomography in the management of stage I and II non-small-cell lung cancer. J Clin Oncol 22:2357\u20132362","journal-title":"J Clin Oncol"},{"key":"670_CR32","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1200\/JCO.2005.02.4695","volume":"24","author":"G.J. Herder","year":"2004","unstructured":"Herder GJ, Kramer H, Hoekstra OS et al; POORT Study Group (2004) Traditional versus up-front 18FDG PET staging of non-small cell lung cancer: a Ducth co-operative randomized study. J Clin Oncol 24:1800\u20131806","journal-title":"J Clin Oncol"},{"key":"670_CR33","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1056\/NEJMoa0900043","volume":"361","author":"B. Fischer","year":"2009","unstructured":"Fischer B, Lassen U, Mortensen J et al (2009) Preoperative staging of lung cancer with combined PET-CT. N Engl J Med 361:32\u201339","journal-title":"N Engl J Med"},{"key":"670_CR34","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.lungcan.2006.08.018","volume":"55","author":"L.F. Geus-Oei De","year":"2007","unstructured":"De Geus-Oei LF, Krieken JH, Aliredjo RP et al (2007) Biological correlates of FDG uptake in non-small cell lung cancer. Lung Cancer 55:79\u201387","journal-title":"Lung Cancer"},{"key":"670_CR35","unstructured":"Groen HJM, Sleijfer DT, de Vries EGE (2005) Positron emission tomography computerized tomography, and endoscopic ultrasound with needle aspiration for lung cancer. American Society of Clinical Oncology (Educational Book), 579\u2013585"},{"key":"670_CR36","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1016\/j.ejca.2008.11.043","volume":"45","author":"P. Gu","year":"2009","unstructured":"Gu P, Zhao YZ, Jiang LY et al (2009) Endobronchial ultrasound-guided transbronchial needle aspiration for staging of lung cancer: a systematic review and meta-analysis. Eur J Cancer 45:1389\u20131396","journal-title":"Eur J Cancer"},{"key":"670_CR37","doi-asserted-by":"crossref","first-page":"8283","DOI":"10.1200\/JCO.2005.08.912","volume":"23","author":"V.W. Rusch","year":"2005","unstructured":"Rusch VW (2005) Mediastinoscopy: an endangered species? J Clin Oncol 23:8283\u20138285","journal-title":"J Clin Oncol"},{"key":"670_CR38","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1007\/s00259-011-1803-3","volume":"38","author":"A.K. Buck","year":"2011","unstructured":"Buck AK, Herrmann K, Schrey\u00f6gg J (2011) PET\/ CT for staging lung cancer: costly or cost-saving? Eur J Nucl Med Mol Imaging 38:799\u2013801","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"670_CR39","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/j.jtcvs.2005.10.045","volume":"131","author":"B.F. Meyers","year":"2006","unstructured":"Meyers BF, Haddad F, Siegel BA et al (2006) Cost-effectiveness of routine mediastinoscopy in computed tomography- and positron emission tomography-screened patients with stage I lung cancer. J Thorac Cardiovasc Surg 131:822\u2013829","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"[Suppl2]","key":"670_CR40","doi-asserted-by":"crossref","first-page":"s75","DOI":"10.1016\/j.lungcan.2004.07.989","volume":"45","author":"D. Ukena","year":"2004","unstructured":"Ukena D, Hellwing D (2004) Value of FDG PET in the management of NSCLC. Lung Cancer 45[Suppl 2]:s75\u2013s78","journal-title":"Lung Cancer"},{"key":"670_CR41","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1016\/0003-4975(95)00752-0","volume":"60","author":"P.E. Valk","year":"1995","unstructured":"Valk PE, Pounds TR, Hopkins DM et al (1995) Staging non-small cell lung cancer by wholebody positron emission tomographic imaging. Ann Thorac Surg 60:1573\u20131581","journal-title":"Ann Thorac Surg"},{"key":"670_CR42","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1016\/S0003-4975(98)00675-4","volume":"66","author":"W. Weder","year":"1998","unstructured":"Weder W, Schmid RA, Bruchlaus H et al (1998) Detection of extrathoracic metastases by positron emission tomography in lung cancer. Ann Thorac Surg 66:886\u2013892","journal-title":"Ann Thorac Surg"},{"key":"670_CR43","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S0360-3016(01)01477-8","volume":"50","author":"M.P. MacManus","year":"2001","unstructured":"MacManus MP, Hicks RJ, Matthews J et al (2001) High rate of detection of unsuspected distant metastases by PET in apparent stage III non-smallcell lung cancer: implications for radical radiation therapy. Int J Radiat Oncol Biol Phys 50:287\u2013293","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"670_CR44","doi-asserted-by":"crossref","first-page":"6846","DOI":"10.1200\/JCO.2005.10.116","volume":"23","author":"D. Lardinois","year":"2005","unstructured":"Lardinois D, Weder W, Roudas M et al (2005) Etiology of solitary extrapulmonary positron emission tomography and computed tomography findings in patients with lung cancer. J Clin Oncol 23:6846\u20136853","journal-title":"J Clin Oncol"},{"key":"670_CR45","doi-asserted-by":"crossref","first-page":"7654","DOI":"10.1200\/JCO.2005.01.4340","volume":"23","author":"J.Y. Choi","year":"2005","unstructured":"Choi JY, Lee KY, Kwon OJ et al (2005) Improved detection of second primary cancer using integrated [18F] fluorodeoxyglucose positron emission tomography and computed tomography for initial tumor staging. J Clin Oncol 23:7654\u20137659","journal-title":"J Clin Oncol"},{"key":"670_CR46","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/S0022-5223(94)70106-7","volume":"107","author":"M. Burt","year":"1994","unstructured":"Burt M, Heelan RT, Coit D et al (1994) Prospective evaluation of unilateral adrenal masses in patients with operable non-small-cell lung cancer: Impact of magnetic resonace imaging. J Thorac Cardiovasc Surg 107:584\u2013588","journal-title":"J Thorac Cardiovasc Surg"},{"key":"670_CR47","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1148\/radiology.212.3.r99se21803","volume":"212","author":"E.M. Marom","year":"1999","unstructured":"Marom EM, McAdams HP, Erasmus JJ et al (1999) Staging non-small cell lung cancer with whole-body PET. Radiology 212:803\u2013809","journal-title":"Radiology"},{"key":"670_CR48","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s00259-005-1915-8","volume":"33","author":"S. Jana","year":"2006","unstructured":"Jana S, Zhang T, Milstein DM et al (2006) FDGPET and CT characterization of adrenal lesions in cancer patients. Eur J Nucl Med Mol Imaging 33:29\u201335","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"670_CR49","first-page":"2058","volume":"45","author":"R. Kumar","year":"2004","unstructured":"Kumar R, Xiu Y, Yu JQ et al (2004) 18F-FDG PET in evaluation of adrenal lesions of patients with lung cancer. J Nucl Med 45:2058\u20132062","journal-title":"J Nucl Med"},{"key":"670_CR50","first-page":"32","volume":"47","author":"U. Metser","year":"2006","unstructured":"Metser U, Miller E, Lerman H et al (2006) 18FFDG PET\/CT in the evaluation of adrenal masses. J Nucl Med 47:32\u201337","journal-title":"J Nucl Med"},{"key":"670_CR51","first-page":"3375","volume":"16","author":"T. Bury","year":"1998","unstructured":"Bury T, Barreto A, Daenen F et al (1998) Fluorine-18 deoxyglucose positron emission tomography for the detection of bone metastases in patients with non-small cell lung cancer. Eur J Nucl Med 16:3375\u20133379","journal-title":"Eur J Nucl Med"},{"key":"670_CR52","doi-asserted-by":"crossref","first-page":"3375","DOI":"10.1200\/JCO.1998.16.10.3375","volume":"16","author":"G.J. Cook","year":"1998","unstructured":"Cook GJ, Houston S, Rubens R et al (1998) Detection of bone metastases in breast cancer by 18FDG PET: Differing metabolic activity in osteoblastic and osteolytic lesions. J Clin Oncol 16:3375\u20133379","journal-title":"J Clin Oncol"},{"key":"670_CR53","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/00003072-199401000-00004","volume":"19","author":"M. Meyer","year":"1994","unstructured":"Meyer M, Gast T, Raja S, Hubner K (1994) Increased F-18 FDG accumulation in an acute fracture. Clin Nucl Med 19:13\u201314","journal-title":"Clin Nucl Med"},{"key":"670_CR54","doi-asserted-by":"crossref","unstructured":"Qu X, Huang X, Yan W et al (2011) A metaanalysis of (18)FDG-PET-CT, (18)FDG-PET, MRI and bone scintigraphy for diagnosis of bone metastases in patients with lung cancer. Eur J Radiol (Epub ahead of print)","DOI":"10.1016\/j.ejrad.2011.01.126"},{"key":"670_CR55","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.clon.2010.10.002","volume":"23","author":"T. Liu","year":"2011","unstructured":"Liu T, Xu JY, Xu W et al (2011) Fluorine-18 deoxyglucose positron emission tomography, magnetic resonance imaging and bone scintigraphy for the diagnosis of bone metastases in patients with lung cancer: which one is the best? \u2014 a metaanalysis. Clin Oncol (R Coll Radiol) 23:350\u2013358","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"670_CR56","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1378\/chest.128.4.2289","volume":"128","author":"B.S. Halpern","year":"2005","unstructured":"Halpern BS, Schiepers C, Weber WA et al (2005) Presurgical staging of non-small cell lung cancer: positron emission tomography, integrated positron emission tomography\/CT, and software image fusion. Chest 128:2289\u20132297","journal-title":"Chest"},{"key":"670_CR57","first-page":"150","volume":"29","author":"M. Sim\u00f3","year":"2006","unstructured":"Sim\u00f3 M, Cirera L, Garc\u00eda-Garzon JR et al (2006) Impacto cl\u00ednico de la PET con 18FDG en la selecci\u00f3n de la terapia de los pacientes oncol\u00f3gicos. Oncolog\u00eda 29:150\u2013157","journal-title":"Oncolog\u00eda"},{"key":"670_CR58","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1053\/srao.2001.18100","volume":"11","author":"D.A. Mankoff","year":"2001","unstructured":"Mankoff DA, Bellon JR (2001) Positron-emission tomographic imaging of cancer: glucose metabolism and beyond. Semin Radiat Oncol 11:16\u201327","journal-title":"Semin Radiat Oncol"},{"key":"670_CR59","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0720-048X(02)00282-6","volume":"45","author":"S. Stroobants","year":"2003","unstructured":"Stroobants S, Verschakelen J, Vansteenkiste J (2003) Value of FDG-PET in the management of non-small cell lung cancer. Eur J Radiol 45:49\u201359","journal-title":"Eur J Radiol"},{"key":"670_CR60","first-page":"3837","volume":"6","author":"H. Veselle","year":"2000","unstructured":"Veselle H, Schmidt RA, Pugley JM et al (2000) Lung cancer proliferation correlates with [F-18] fluorodeoxyglucose uptake by positron emission tomography. Clin Cancer Res 6:3837\u20133844","journal-title":"Clin Cancer Res"},{"key":"670_CR61","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1200\/JCO.20.2.379","volume":"20","author":"R. Bos","year":"2002","unstructured":"Bos R, Van der Hoeven JJ, Van Der Wall E et al (2002) Biologic correlates of (18)flurodeoxyglucose uptake in human breast cancer mesasured by positron emission tomography. J Clin Oncol 20:379\u2013387","journal-title":"J Clin Oncol"},{"key":"670_CR62","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1016\/0003-4975(95)00754-9","volume":"60","author":"F.G. Duhaylongsod","year":"1995","unstructured":"Duhaylongsod FG, Lowe VJ, Patz EF et al (1995) Lung tumor growth correlates with glucose metabolism measured by fluride-18-fluodeoxygluose positron emission tomography. Ann Thorac Surg 60:1348\u20131352","journal-title":"Ann Thorac Surg"},{"key":"670_CR63","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1002\/(SICI)1097-0142(19980901)83:5<918::AID-CNCR17>3.0.CO;2-Y","volume":"83","author":"V. Ahuja","year":"1998","unstructured":"Ahuja V, Coleman RE, Herndon J, Patz EF (1998) The prognostic significance of fluorodeoxyglucose positron emission tomography imaging for patients with non-small-cell-lung carcinoma. Cancer 83:918\u2013924","journal-title":"Cancer"},{"key":"670_CR64","doi-asserted-by":"crossref","first-page":"3201","DOI":"10.1200\/JCO.1999.17.10.3201","volume":"17","author":"J.F. Vansteenkiste","year":"1999","unstructured":"Vansteenkiste JF, Stroobants SG, Dupont PJ et al (1999) Prognostic importance of the standardized uptake value on FDG-PET scan in non-small-cell lung cancer: an analysis of 125 cases. J Clin Oncol 17:3201\u20133206","journal-title":"J Clin Oncol"},{"key":"670_CR65","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S1010-7940(00)00535-2","volume":"18","author":"K. Dhital","year":"2000","unstructured":"Dhital K, Saunders CA, Seed PT et al (2000) [18F] Fluorodeoxyglucose positron emission tomography and its prognostic value in lung cancer. Eur J Cardiothorac Surg 18:425\u2013428","journal-title":"Eur J Cardiothorac Surg"},{"key":"670_CR66","first-page":"39","volume":"43","author":"K. Higashi","year":"2002","unstructured":"Higashi K, Ueda Y, Arisaka Y et al (2002) 18FFDG uptake as a biologic prognostic for factor recurrence in patients with surgically resected non-small cell lung cancer. J Nucl Med 43:39\u201345","journal-title":"J Nucl Med"},{"key":"670_CR67","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1097\/00006231-200209000-00010","volume":"23","author":"H.J. Jeong","year":"2002","unstructured":"Jeong HJ, Min JJ, Park JM et al (2002) Determination of the prognostic value of [(18) F]fluorodeoxyglucose uptake by using positron emission tomography in patients with non-small cell lung cancer. Nucl Med Commun 23:865\u2013870","journal-title":"Nucl Med Commun"},{"key":"670_CR68","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1016\/j.ejca.2005.03.026","volume":"41","author":"G.R. Borst","year":"2005","unstructured":"Borst GR, Belderbos JSA, Boellaard R et al (2005) Captaci\u00f3n de FDG estandarizada: un factor pron\u00f3stico en el c\u00e1ncer de pulm\u00f3n no microc\u00edtico inoperable. Eur J Cancer (ed. espa\u00f1ola) 41:1533\u20131541","journal-title":"Eur J Cancer (ed. espa\u00f1ola)"},{"key":"670_CR69","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1200\/JCO.2005.06.129","volume":"23","author":"R. Sasaki","year":"2005","unstructured":"Sasaki R, Komaki R, Macapinlac H et al (2005) [18F] Fluorodeoxyglucose uptake by positron emission tomography predicts outcome of nonsmall-cell lung cancer. J Clin Oncol 23:1136\u20131143","journal-title":"J Clin Oncol"},{"key":"670_CR70","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.jtcvs.2007.09.029","volume":"135","author":"B.E. Lee","year":"2008","unstructured":"Lee BE, Redwine J, Foster C et al (2008) Mediastinoscopy might not be necessary in patients with non-small cell lung cancer with mediastinal lymph nodes having a maximum standardized uptake value of less than 5.3. J Thorac Cardiovasc Surg 135:615\u2013619","journal-title":"J Thorac Cardiovasc Surg"},{"key":"670_CR71","first-page":"983","volume":"49","author":"W.A. Weber","year":"2005","unstructured":"Weber WA (2005) Use of PET for monitoring cancer therapy and for predicting outcome. J Nucl Med 49:983\u2013995","journal-title":"J Nucl Med"},{"key":"670_CR72","doi-asserted-by":"crossref","first-page":"3255","DOI":"10.1200\/JCO.2004.11.109","volume":"22","author":"R.J. Downey","year":"2004","unstructured":"Downey RJ, Akhurts T, Gonen M et al (2004) Preoperative F-18 fluorodeoxyglucose-positron emission tomography maximal standardized uptake value predicts survival after lung cancer resection. J Clin Oncol 22:3255\u20133260","journal-title":"J Clin Oncol"},{"key":"670_CR73","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1007\/s00259-004-1626-6","volume":"31","author":"A. Stahl","year":"2004","unstructured":"Stahl A, Ott K, Schwaiger M, Weber WA (2004) Comparison of different SUV-based methods for monitoring cytotoxic therapy with FDG PET. Eur J Nucl Med Mol Imaging 31:1471\u20131478","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"670_CR74","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1097\/JTO.0b013e31815e6d6b","volume":"3","author":"T. Berghmans","year":"2008","unstructured":"Berghmans T, Dusart M, Paesmans M et al; European Lung Cancer Working Party for the IASLC Lung Cancer Staging Project (2008) Primary tumor standarized uptake value (SUVmax) measured on fluorodeoxyglucose positron emission tomography (FDG-PET) is of prognostic value for survival in non-small cell lung cancer (NSCLC): a systematic review and meta-analysis (MA) by the European Lung Cancer Working Party for the IASLC Lung Cancer Staging Project. J Thorac Oncol 3:6\u201312","journal-title":"J Thorac Oncol"},{"key":"670_CR75","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1378\/chest.120.5.1584","volume":"120","author":"K. Junker","year":"2001","unstructured":"Junker K, Langner K, Klinke F et al (2001) Grading of tumor regression in non-small-cell lung cancer: morphology and prognosis. Chest 120: 1584\u20131591","journal-title":"Chest"},{"key":"670_CR76","first-page":"1838","volume":"45","author":"T. Yamane","year":"2004","unstructured":"Yamane T, Daimaru O, Ito S et al (2004) Decreased 18F-FDG uptake 1 day after initiation of chemotherapy for malignant lymphomas. J Nucl Med 45:1838\u20131842","journal-title":"J Nucl Med"},{"key":"670_CR77","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1200\/JCO.2001.19.2.414","volume":"19","author":"K. Spaepen","year":"2001","unstructured":"Spaepen K, Stroobants S, Dupont P et al (2001) Prognostic value of positron emission tomography (PET) with fluorine-18 fluorodeoxyglucose ([18]FDG) after first-line chemotherapy in non-Hodgkin\u2019s lymphoma: is [18]FDG-PET a valid alternative to conventional diagnostic methods? J Clin Oncol 19:414\u2013419","journal-title":"J Clin Oncol"},{"key":"670_CR78","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1093\/annonc\/mdf081","volume":"13","author":"P. Flamen","year":"2002","unstructured":"Flamen P, Van Custem E, Lerut A et al (2002) Positron emission tomography for assessment of the response to induction radiochemotherapy in locally advanced oesophageal cancer. Ann Oncol 13:361\u2013368","journal-title":"Ann Oncol"},{"key":"670_CR79","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1200\/JCO.2004.07.122","volume":"22","author":"H.A. Wieder","year":"2004","unstructured":"Wieder HA, Br\u00fccher BL, Zimmermann F et al (2004) Time course of tumor metabolic activity during chemoradiotherapy of esophageal squamous cell carcinoma and response to treatment. J Clin Oncol 22:900\u2013908","journal-title":"J Clin Oncol"},{"key":"670_CR80","doi-asserted-by":"crossref","first-page":"4604","DOI":"10.1200\/JCO.2003.06.574","volume":"21","author":"K. Ott","year":"2003","unstructured":"Ott K, Fink U, Becker K et al (2003) Prediction of response to preoperative chemotherapy in gastric carcinoma by metabolic imaging: results of a prospective trial. J Clin Oncol 21:4604\u20134610","journal-title":"J Clin Oncol"},{"key":"670_CR81","first-page":"1637","volume":"40","author":"M. Schulte","year":"1999","unstructured":"Schulte M, Brecht-Krauss D, Werner M et al (1999) Evaluation of neoadjuvant therapy response of osteogenic sarcoma using FDG PET. J Nucl Med 40:1637\u20131643","journal-title":"J Nucl Med"},{"key":"670_CR82","doi-asserted-by":"crossref","first-page":"5659","DOI":"10.1158\/1078-0432.CCR-06-0368","volume":"12","author":"H. Su","year":"2006","unstructured":"Su H, Bodenstein C, Dumont RA et al (2006) Monitoring tumor glucose utilization by positron emission tomography for the prediction of treatment response to epidermal growth factor receptor kinase inhibitors. Clin Cancer Res 12:5659\u20135667","journal-title":"Clin Cancer Res"},{"key":"670_CR83","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1634\/theoncologist.2010-0300","volume":"16","author":"R.H. Mak","year":"2011","unstructured":"Mak RH, Digumarthy SR, Muzikansky A et al (2011) Role of 18F-fluorodeoxyglucose positron emission tomography in predicting epidermal growth factor receptor mutations in non-small cell lung cancer. Oncologist 16:319\u2013326","journal-title":"Oncologist"},{"key":"670_CR84","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/BF03165392","volume":"10","author":"Y. Ichiya","year":"1996","unstructured":"Ichiya Y, Kuwabara Y, Sasaki M et al (1996) A clinical evaluation of FDG-PET to assess the response in radiation therapy for bronchogenic carcinoma. Ann Nucl Med 10:193\u2013200","journal-title":"Ann Nucl Med"},{"key":"670_CR85","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/S0360-3016(02)03038-9","volume":"54","author":"N.C. Choi","year":"2002","unstructured":"Choi NC, Fischman AJ, Niemierko A et al (2002) Dose-response relationship between probability of pathologic tumor control and glucose metabolic rate measured with FDG PET after preoperative chemoradiotherapy in locally advanced nonsmall-cell lung cancer. Int J Radiat Oncol Biol Phys 54:1024\u20131035","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"670_CR86","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1200\/JCO.2003.07.054","volume":"21","author":"M.P. MacManus","year":"2003","unstructured":"MacManus MP, Hicks RJ, Matthews JP et al (2003) Positron emission tomography is superior to computed tomography scanning for responseassessment after radical radiotherapy or chemoradiotherapy in patients with non-small-cell lung cancer. J Clin Oncol 21:1285\u20131292","journal-title":"J Clin Oncol"},{"key":"670_CR87","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0169-5002(01)00332-4","volume":"35","author":"J.S. Ryu","year":"2002","unstructured":"Ryu JS, Choi NC, Fischman AJ et al (2002) FDGPET in staging and restaging non-small cell lung cancer after neoadjuvant chemoradiotherapy: correlation with histopathology. Lung Cancer 35:179\u2013187","journal-title":"Lung Cancer"},{"key":"670_CR88","doi-asserted-by":"crossref","first-page":"2651","DOI":"10.1200\/JCO.2003.12.004","volume":"21","author":"W.A. Webwer","year":"2003","unstructured":"Webwer WA, Petersen V, Schmidt B et al (2003) Positron emission tomography in non-small cell lung cancer: prediction of response to chemotherapy by quantitative assessment of glucose use. J Clin Oncol 21:2651\u20132692","journal-title":"J Clin Oncol"},{"key":"670_CR89","doi-asserted-by":"crossref","first-page":"8362","DOI":"10.1200\/JCO.2005.01.1189","volume":"23","author":"C.J. Hoeskstra","year":"2005","unstructured":"Hoeskstra CJ, Stroobants SG, Smit EF et al (2005) Prognostic relevance of response evaluation using [18F]-2-Fluoro-2-deoxi-D-glucose positron emission tomography in patients with locally advanced non-small-cell lung cancer. J Clin Oncol 23:8362\u20138370","journal-title":"J Clin Oncol"},{"key":"670_CR90","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1002\/jso.21525","volume":"101","author":"A.C. Rebollo-Aguirre","year":"2010","unstructured":"Rebollo-Aguirre AC, Ramos-Font C, Villegas Portero R et al (2010) Is FDG-PET suitable for evaluating neoadjuvant therapy in non-small cell lung cancer? Evidence with systematic review of the literature. J Surg Oncol 101:486\u2013494","journal-title":"J Surg Oncol"},{"key":"670_CR91","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1007\/s002590050570","volume":"27","author":"C.J. Hoekstra","year":"2000","unstructured":"Hoekstra CJ, Paglianiti I, Hekstra OS et al (2000) Monitoring response to therapy in cancer using [18F]-2-fluoro-2-deoxy-D-glucose and positron emission tomography: an overview of different analytical methods. Eur J Nucl Med 27:731\u2013743","journal-title":"Eur J Nucl Med"},{"key":"670_CR92","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/s00259-006-0273-5","volume":"34","author":"S.M. Eschmann","year":"2007","unstructured":"Eschmann SM, Friedel G, Paulsen F et al (2007) 18F-FDG PET for assessment of therapy response and preoperative re-evaluation after neoadjuvant radio-chemotherapy in stage III non-small cell lung cancer. Eur J Nucl Med Mol Imaging 34: 463\u2013471","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"670_CR93","doi-asserted-by":"crossref","first-page":"3304","DOI":"10.1158\/1078-0432.CCR-10-2763","volume":"17","author":"L. Mileshkin","year":"2011","unstructured":"Mileshkin L, Hicks RJ, Hughes BG et al (2011) Changes in 18F-fluorodeoxyglucose and 18F-fluorodeoxythymidine positron emission tomography imaging in patients with non-small cell lung cancer treated with erlotinib. Clin Cancer Res 17:3304\u20133315","journal-title":"Clin Cancer Res"},{"key":"670_CR94","doi-asserted-by":"crossref","first-page":"243S","DOI":"10.1378\/chest.07-1379","volume":"132","author":"L.A. Robinson","year":"2007","unstructured":"Robinson LA, Ruckdeschel JC, Wagner H Jr, Stevens CW; American College of Chest Physicians (2007) Treatment of non-small cell lung cancerstage IIIA: ACCP evidence based clinical practice guidelines (2nd edition). Chest 132:243S\u2013265S","journal-title":"Chest"},{"key":"670_CR95","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/S0360-3016(03)00346-8","volume":"57","author":"I.F. Ciernik","year":"2003","unstructured":"Ciernik IF, Dizendorf E, Baumert BG et al (2003) Radiation treatment planning with an integrated positron emission and computer tomography (PET\/CT): a feasibility study. Int J Rad Oncol Biol Phys 57:853\u2013863","journal-title":"Int J Rad Oncol Biol Phys"},{"key":"670_CR96","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.ijrobp.2004.06.205","volume":"61","author":"A. Wel Van Der","year":"2005","unstructured":"Van Der Wel A, Nijsten S, Hochstenbag M et al (2005) Increased therapeutic ratio by 18FDG-PET CT planning in patients with clinical CT stage N2-N3 M0 non-small-cell lung cancer: a modeling study. Int J Radiat Oncol Biol Phys 61:649\u2013655","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"670_CR97","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/S0360-3016(01)01824-7","volume":"52","author":"K. Mah","year":"2002","unstructured":"Mah K, Caldwell C, Ung Y et al (2002) The impact of (18)FDG-PET on target and critical organs in CT-based treatment planning of patients with poorly defined non-small cell lung carcinoma: a prospective study. Int J Radiat Oncol Biol Phys 52:339\u2013350","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"670_CR98","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0167-8140(01)00453-4","volume":"62","author":"J. Steene Van de","year":"2002","unstructured":"Van de Steene J, Linthout N, de Mey J et al (2002) Definition of gross tumor volume in lung cancer: interobserver variability. Radiother Oncol 62:37\u201349","journal-title":"Radiother Oncol"},{"key":"670_CR99","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.radonc.2005.09.017","volume":"24","author":"R.J. Steenbakkers","year":"2005","unstructured":"Steenbakkers RJ, Duppen JC, Fitton I et al (2005) Observer variation in target volume delineation of lung cancer related to radiation oncologistcomputer interaction: a \u201cBig Brother\u201d evaluation. Radiother Oncol 24:182\u2013190","journal-title":"Radiother Oncol"},{"key":"670_CR100","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0167-8140(01)00470-4","volume":"62","author":"Y.E. Erdi","year":"2002","unstructured":"Erdi YE, Rosenzweig K, Erdi AK et al (2002) Radiotherapy treatment planning for patients with non-small cell lung cancer using positron emission tomography (PET). Radiother Oncol 62:51\u201360","journal-title":"Radiother Oncol"},{"key":"670_CR101","first-page":"181","volume":"2","author":"M. Kunkel","year":"1998","unstructured":"Kunkel M, Wahlmann U, Gr\u00f6tz KA et al (1998) [Value of (F18)-2-fluorodeoxyglucose PET scanning in staging mouth cavity carcinoma. Comparative evaluation of PET findings before and after preoperative radiochemotherapy with histological and computerized tomography findings]. Mund Kiefer Gesichtschir 2:181\u2013187","journal-title":"Comparative evaluation of PET findings before and after preoperative radiochemotherapy with histological and computerized tomography findings]. Mund Kiefer Gesichtschir"},{"key":"670_CR102","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0169-5002(99)00005-7","volume":"23","author":"M.T. Munley","year":"1999","unstructured":"Munley MT, Marks LB, Scarfone C et al (1999) Multimodality nuclear medicine imaging in threedimensional radiation treatment planning for lung cancer: challenges and prospects. Lung Cancer 23:105\u2013114","journal-title":"Lung Cancer"},{"key":"670_CR103","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/S0360-3016(99)00061-9","volume":"44","author":"U. Nestle","year":"1999","unstructured":"Nestle U, Walter K, Schmidt S et al (1999) 18Fdeoxyglucose positron emission tomography (FDG-PET) for the planning of radiotherapy in lung cancer: high impact in patients with atelectasis. Int J Radiat Oncol Biol Phys 44:593\u2013597","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"670_CR104","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/S1278-3218(01)00135-4","volume":"5","author":"P. Giraud","year":"2001","unstructured":"Giraud P, De Rycke Y, Minet P et al (2001) Estimation of the probability of mediastinal involvement: a statistical definition of the clinical target volume for 3-dimensional conformal radiotherapy in non-small-cell lung cancer? Cancer Radiother 5:725\u2013736","journal-title":"Cancer Radiother"},{"key":"670_CR105","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/S0360-3016(01)01722-9","volume":"51","author":"C.B. Caldwell","year":"2001","unstructured":"Caldwell CB, Mah K, Ung YC et al (2001) Observer variation in contouring gross tumor volume in patients with poorly defined non-small-cell lung tumors on CT: the impact of 18FDG-hybrid PET fusion. Int J Radiat Oncol Biol Phys 51:923\u2013931","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"670_CR106","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1002\/1097-0142(20010815)92:4<886::AID-CNCR1397>3.0.CO;2-V","volume":"92","author":"M.P. MacManus","year":"2001","unstructured":"MacManus MP, Hicks RJ, Ball DL et al (2001) F-18 fluorodeoxyglucose positron emission tomography staging in radical radiotherapy candidates with nonsmall cell lung carcinoma: powerful correlation with survival and high impact on treatment. Cancer 92:886\u2013895","journal-title":"Cancer"},{"key":"670_CR107","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/j.ijrobp.2005.04.021","volume":"63","author":"H. Ashamalla","year":"2005","unstructured":"Ashamalla H, Rafla S, Parikh K et al (2005) The contribution of integrated PET\/CT to the evolving definition of treatment volumes in radiation treatment planning in lung cancer. Int J Radiat Oncol Biol Phys 63:1016\u20131023","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"670_CR108","first-page":"259","volume":"49","author":"C. Messa","year":"2005","unstructured":"Messa C, Ceresoli GL, Rizzo G et al (2005) Feasibility of [18F]FDG-PET and coregistered CT on clinical target volume definition of advanced non-small cell lung cancer. Q J Nucl Med Mol Imaging 49:259\u2013266","journal-title":"Q J Nucl Med Mol Imaging"},{"key":"670_CR109","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S0167-8140(00)00138-9","volume":"55","author":"L. Vanuystel","year":"2000","unstructured":"Vanuystel L, Vansteenkiste J, Stroobants S et al (2000) The impact of 18F-fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) lymph node staging on the radiation treatment volumes in patients with non-small cell lung cancer. Radiother Oncol 55:317\u2013324","journal-title":"Radiother Oncol"},{"key":"670_CR110","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.ijrobp.2003.10.044","volume":"59","author":"J. Bradley","year":"2004","unstructured":"Bradley J, Thorstad WL, Mutic S et al (2004) Impact of FDG-PET on radiation therapy volume delineation in non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 59:78\u201386","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"670_CR111","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1016\/j.ijrobp.2005.05.016","volume":"63","author":"E. Deniaud-Alexandre","year":"2005","unstructured":"Deniaud-Alexandre E, Touboul E, Lerouge D et al (2005) Impact of computed tomography and 18F-Deoxyglucose coincidence detection emission tomography image fusion for optimization of conformal radiotherapy in non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 63:1432\u20131441","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"670_CR112","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.2214\/AJR.05.0712","volume":"187","author":"J.F. Bruzzi","year":"2006","unstructured":"Bruzzi JF, Truong MT, Marom EM et al (2006) Incidental findings on integrated PET\/CT that do not accumulate 18F-FDG. AJR Am J Roentgenol 187:1116\u20131123","journal-title":"AJR Am J Roentgenol"},{"key":"670_CR113","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1097\/00004728-200307000-00004","volume":"27","author":"S.L. Aquino","year":"2003","unstructured":"Aquino SL, Asmuth JC, Alpert NM et al (2003) Improved radiologic staging of lung cancer with 2-[18F]-fluoro-2-deoxy-D-glucose-positron emission tomography and computed tomography registration. J Comput Assist Tomogr 27:479\u2013484","journal-title":"J Comput Assist Tomogr"},{"key":"670_CR114","first-page":"479","volume":"27","author":"J.A. Verschakelen","year":"2004","unstructured":"Verschakelen JA, De Wever W, Bogaert J (2004) Role of computed tomography in lung cancer staging. Curr Opin Pulm Med 27:479\u2013484","journal-title":"Curr Opin Pulm Med"},{"key":"670_CR115","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/j.athoracsur.2004.02.067","volume":"78","author":"R.J. Cerfolio","year":"2004","unstructured":"Cerfolio RJ, Ojha B, Bryant AS et al (2004) The accuracy of integrated PET-CT compared with dedicated PET alone for the staging of patients with nonsmall cell lung cancer. Ann Thorac Surg 78:1017\u20131023","journal-title":"Ann Thorac Surg"},{"key":"670_CR116","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1148\/radiol.2292021598","volume":"229","author":"G. Antoch","year":"2003","unstructured":"Antoch G, Stattaus J, Nemat AT et al (2003) Nonsmall cell lung cancer: dual-modality PET\/CT in preoperative staging. Radiology 229:526\u2013533","journal-title":"Radiology"},{"key":"670_CR117","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1378\/chest.112.6.1480","volume":"112","author":"J.F. Vansteenkiste","year":"1997","unstructured":"Vansteenkiste JF, Stroobants SG, De Leyn PR et al (1997) Mediastinal lymph node staging with FDG-PET scan in patients with potentially operable non-small cell lung cancer: a prospective analysis of 50 cases. Chest 112:1480\u20131486","journal-title":"Chest"},{"key":"670_CR118","first-page":"741","volume":"40","author":"P. Magnani","year":"1999","unstructured":"Magnani P, Carretta A, Rizzo G et al (1999) FDG\/ PET and spiral CT image fusion for medistinal lymph node assessment of non-small cell lung cancer patients. J Cardiovasc Surg 40:741\u2013748","journal-title":"J Cardiovasc Surg"},{"key":"670_CR119","doi-asserted-by":"crossref","first-page":"8348","DOI":"10.1200\/JCO.2004.00.6361","volume":"23","author":"F. Pozo-Rodr\u00edguez","year":"2005","unstructured":"Pozo-Rodr\u00edguez F, Mart\u00edn de Nicol\u00e1s JL, S\u00e1nchez-Nistal MA et al (2005) Accuracy of helical computed tomography and [18F] Fluorodeoxyglucose positron emission tomography for identifying lymph node mediastinal metastases in potencially resectable non-small-cell lung cancer. J Clin Oncol 23:8348\u20138356","journal-title":"J Clin Oncol"},{"key":"670_CR120","first-page":"1200","volume":"44","author":"R. Bar-Shalom","year":"2003","unstructured":"Bar-Shalom R, Yefremov N, Guralnik L et al (2003) Clinical performance of PET\/CT in evaluation of cancer: additional value for diagnostic imaging and patient managememt. J Nucl Med 44:1200\u20131209","journal-title":"J Nucl Med"},{"key":"670_CR121","unstructured":"Rodr\u00edguez Garrido M, Asensio del Barrio C (2004) PET-TAC: Indicaciones, revisi\u00f3n sistem\u00e1tica y meta-an\u00e1lisis. AETS-Instituto de Salud Carlos III"},{"key":"670_CR122","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1148\/radiol.2363041310","volume":"236","author":"S.S. Shim","year":"2005","unstructured":"Shim SS, Lee KS, Kim BT et al (2005) Non-small cell lung cancer: prospective comparison of integrated FDG PET\/T and CT alone for preoperative staging. Radiology 236:1011\u20131019","journal-title":"Radiology"},{"key":"670_CR123","first-page":"1596","volume":"42","author":"R.J. Hicks","year":"2001","unstructured":"Hicks RJ, Kalff V, MacManus MP et al (2001) [18F]FDG PET provides high-impact and powerful prognostic stratification in staging newly diagnosed non-small cell lung cancer. J Nucl Med 42:1596\u20131604","journal-title":"J Nucl Med"},{"key":"670_CR124","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/978-3-642-59349-9_19","volume":"162","author":"M. Schm\u00fccking","year":"2003","unstructured":"Schm\u00fccking M, Baum RP, Griesinger F et al (2003) Molecular whole-body cancer staging using positron emission tomography: consequences for therapeutic management and metabolic radiation treatment planning. Recent Results Cancer Res 162:195\u2013202","journal-title":"Recent Results Cancer Res"},{"key":"670_CR125","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0169-5002(97)00086-X","volume":"19","author":"J.D. Kiffer","year":"1998","unstructured":"Kiffer JD, Berlangieri SU, Scott AM et al (1998) The contribution of 18F-fluoro-2-deoxy-glucose positron emission tomographic imaging to radiotherapy planning in lung cancer. Lung Cancer 19:167\u2013177","journal-title":"Lung Cancer"}],"container-title":["Clinical and Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-011-0670-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12094-011-0670-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-011-0670-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,27]],"date-time":"2021-11-27T04:15:44Z","timestamp":1637986544000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12094-011-0670-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,6]]},"references-count":125,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2011,6]]}},"alternative-id":["670"],"URL":"https:\/\/doi.org\/10.1007\/s12094-011-0670-5","relation":{},"ISSN":["1699-048X","1699-3055"],"issn-type":[{"value":"1699-048X","type":"print"},{"value":"1699-3055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,6]]}}}